Skip to main content

Peer Review reports

From: Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells

Original Submission
6 Jun 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Jun 2014 Author responded Author comments - Yi Chen
Resubmission - Version 3
10 Jun 2014 Submitted Manuscript version 3
22 Sep 2014 Reviewed Reviewer Report - Liming Zhou
6 Oct 2014 Author responded Author comments - Yi Chen
Resubmission - Version 4
6 Oct 2014 Submitted Manuscript version 4
10 Oct 2014 Author responded Author comments - Yi Chen
Resubmission - Version 5
10 Oct 2014 Submitted Manuscript version 5
Publishing
14 Oct 2014 Editorially accepted
24 Oct 2014 Article published 10.1186/2050-6511-15-59

You can find further information about peer review here.

Back to article page